163 related articles for article (PubMed ID: 31480474)
1. Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets.
Roszik J; Khan A; Conley AP; Livingston JA; Groisberg R; Ravi V; Carmagnani Pestana R; Sen S; Subbiah V
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31480474
[TBL] [Abstract][Full Text] [Related]
2. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets.
Cui Y; Han L; Shang J; Fang W; Zhao M; Chen D; Liu H
Hum Pathol; 2022 May; 123():113-122. PubMed ID: 35181378
[TBL] [Abstract][Full Text] [Related]
3. Activating mutation of
Fu X; Niu W; Li J; Kiliti AJ; Al-Ahmadie HA; Iyer G; Gao SP; Li Q
Oncotarget; 2017 Oct; 8(46):81709-81716. PubMed ID: 29113426
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
6. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
7. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract][Full Text] [Related]
8. Analysis of histology-agnostic targets among soft tissue and bone sarcomas in the AACR GENIE database.
Pestana RC; Serrano C
Front Oncol; 2022; 12():1079909. PubMed ID: 36741731
[TBL] [Abstract][Full Text] [Related]
9. Undifferentiated Sarcomas in Children Harbor Clinically Relevant Oncogenic Fusions and Gene Copy-Number Alterations: A Report from the Children's Oncology Group.
Laetsch TW; Roy A; Xu L; Black JO; Coffin CM; Chi YY; Tian J; Spunt SL; Hawkins DS; Bridge JA; Parsons DW; Skapek SX
Clin Cancer Res; 2018 Aug; 24(16):3888-3897. PubMed ID: 29691299
[No Abstract] [Full Text] [Related]
10. The Landscape of Alterations from 1407 Ultra-Rare Sarcomas from the AACR GENIE Database: Clinical Implications.
Denu RA; Moyers JT; Gouda MA; Conley AP; Lazar AJ; Subbiah V
Clin Cancer Res; 2023 Nov; 29(22):4669-4678. PubMed ID: 37643131
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Griewank KG; Wiesner T; Murali R; Pischler C; Müller H; Koelsche C; Möller I; Franklin C; Cosgarea I; Sucker A; Schadendorf D; Schaller J; Horn S; Brenn T; Mentzel T
Mod Pathol; 2018 Mar; 31(3):418-428. PubMed ID: 29099504
[TBL] [Abstract][Full Text] [Related]
13. Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal.
Lopes-Brás R; Lopez-Presa D; Esperança-Martins M; Melo-Alvim C; Gallego L; Costa L; Fernandes I
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430703
[TBL] [Abstract][Full Text] [Related]
14. Intimal Sarcoma with MDM2/CDK4 Amplification and p16 Overexpression: A Review of Histological Features in Primary Tumor and Xenograft, with Immunophenotype and Molecular Profiling.
Giner F; Machado I; Rubio-Martínez LA; López-Guerrero JA; Claramunt-Alonso R; Navarro S; Ferrández A; Mayordomo-Aranda E; Llombart-Bosch A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108696
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma.
Suehara Y; Kohsaka S; Hayashi T; Akaike K; Kurisaki-Arakawa A; Sato S; Kobayashi E; Mizuno S; Ueno T; Morii T; Okuma T; Kurihara T; Hasegawa N; Sano K; Sasa K; Okubo T; Kim Y; Mano H; Saito T
Clin Orthop Relat Res; 2021 Apr; 479(4):838-852. PubMed ID: 33196586
[TBL] [Abstract][Full Text] [Related]
16. Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature.
Koelsche C; Benhamida JK; Kommoss FKF; Stichel D; Jones DTW; Pfister SM; Heilig CE; Fröhling S; Stenzinger A; Buslei R; Mentzel T; Baumhoer D; Ladanyi M; Antonescu CR; Flucke U; Gorp JV; Bode-Lesniewska B; Deimling AV; Mechtersheimer G
Mod Pathol; 2021 Dec; 34(12):2122-2129. PubMed ID: 34312479
[TBL] [Abstract][Full Text] [Related]
17. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
18. MDM2 dual-color in situ hybridization (DISH) aids the diagnosis of intimal sarcomas.
Jimbo N; Komatsu M; Itoh T; Hirose T
Cardiovasc Pathol; 2019; 43():107142. PubMed ID: 31442826
[TBL] [Abstract][Full Text] [Related]
19. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma.
Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT
JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798
[TBL] [Abstract][Full Text] [Related]
20. A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
Vasan N; Yelensky R; Wang K; Moulder S; Dzimitrowicz H; Avritscher R; Wang B; Wu Y; Cronin MT; Palmer G; Symmans WF; Miller VA; Stephens P; Pusztai L
Oncologist; 2014 May; 19(5):453-8. PubMed ID: 24710307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
